Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lumisque is an aesthetics and healthcare company focused on the development of non-invasive carboxytherapy treatments for skin and sexual wellness. The company's proprietary technology, marketed under the CO2Lift brand, facilitates the topical delivery of carbon dioxide to stimulate the Bohr Effect, which increases oxygenation and blood flow to localized tissues. Its primary product lines include CO2Lift Pro, used for facial rejuvenation and post-aesthetic procedure recovery, and CO2LiftV, which targets vaginal health and vulvovaginal atrophy. Lumisque serves the professional medical market, providing solutions for dermatologists, plastic surgeons, and gynecologists looking for needle-free regenerative options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lumisque.